Fast molecular turnaround
Priority handling for oncology cases, so treatment decisions aren't held up waiting for results.
Oncology is Nova Labs' dedicated cancer-diagnostics group for oncology teams — tumour profiling, liquid biopsy, molecular pathology, and therapy-response monitoring that guide targeted, personalised treatment, with results delivered through our app.
What we offer
A focused cancer-diagnostics service for oncologists — from first molecular profile to ongoing response monitoring, backed by Nova Labs and international partner labs for specialised assays.
Biomarker profiling including HER2, EGFR, KRAS, and PD-L1, plus multi-gene panels to guide targeted and immuno-therapy decisions.
Circulating tumour DNA (ctDNA) from a simple blood draw for non-invasive detection, monitoring, and resistance tracking.
Tissue-based molecular diagnostics and companion testing to match patients to the right therapy.
Germline testing including BRCA1/2 and Lynch syndrome for inherited cancer risk and family screening.
Leukaemia and lymphoma panels and molecular markers, with monitoring for haematological malignancies.
Serial biomarker and immunotherapy-response testing to track how tumours respond over the course of treatment.
Built for oncology teams
Priority handling for oncology cases, so treatment decisions aren't held up waiting for results.
Clear, actionable reports delivered through our app, with the treating oncologist notified the moment results are validated.
Where a test isn't available locally, we coordinate with certified international partner labs to run it.
Talk to us about profiling panels, liquid biopsy, and reporting workflows for your patients — or refer a case directly.